Clinical Site

Paris 75908

0 studies enrolling now · 3 studies all time

What they study most

C3 Glomerulopathy (C3G), In-situ Small Bowel T-cell Lymphoma, Respiratory Syncytial Virus Infections, Type II Refractory Celiac Disease (RCD-II)

Studies at this site

• Controlled Trial Evaluating Avacopan in C3 Glomerulopathy — Completed
• Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Type II Refractory Celiac Disease — Completed
• Phase 2b Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV) — Completed